{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:34:48Z","timestamp":1772930088925,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.coviro.2016.09.003","type":"journal-article","created":{"date-parts":[[2016,9,18]],"date-time":"2016-09-18T03:46:22Z","timestamp":1474170382000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The quest for host targets to combat dengue virus infections"],"prefix":"10.1016","volume":"20","author":[{"given":"Eliana G","family":"Acosta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.09.003_bib0420","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.09.003_bib0425","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.2016.1121814","article-title":"Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development","volume":"15","author":"Acosta","year":"2016","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.coviro.2016.09.003_bib0430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0435","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten years of dengue drug discovery: progress and prospects","volume":"100","author":"Lim","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800098-4.00001-5","article-title":"Revisiting dengue virus\u2013host cell interaction: new insights into molecular and cellular virology","volume":"88","author":"Acosta","year":"2014","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/v6010069","article-title":"Flavivirus entry receptors: an update","volume":"6","author":"Perera-Lecoin","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2016.09.003_bib0450","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/femsre\/fuu004","article-title":"Receptors and routes of dengue virus entry into the host cells","volume":"39","author":"Cruz-Oliveira","year":"2015","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.coviro.2016.09.003_bib0455","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2016.09.003_bib0460","first-page":"761","article-title":"Dengue virus strain DEN2 16681 utilizes a specific glycochain of syndecan-2 proteoglycan as a receptor","volume":"93","author":"Okamoto","year":"2012","journal-title":"J GenVirol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0465","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","article-title":"Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses","volume":"69","author":"Lee","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0470","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.virol.2007.01.043","article-title":"Interference in dengue virus adsorption and uncoating by carrageenans","volume":"363","author":"Talarico","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/095632020201300202","article-title":"Novel dl-galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus","volume":"13","author":"Pujol","year":"2002","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.coviro.2016.09.003_bib0480","doi-asserted-by":"crossref","first-page":"e2188","DOI":"10.1371\/journal.pntd.0002188","article-title":"Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry\/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application","volume":"7","author":"Ichiyama","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0485","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2005.02.001","article-title":"The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell","volume":"66","author":"Talarico","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0490","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2009.01.043","article-title":"Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection","volume":"387","author":"Alen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0495","doi-asserted-by":"crossref","first-page":"e21658","DOI":"10.1371\/journal.pone.0021658","article-title":"Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells","volume":"6","author":"Alen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2016.09.003_bib0500","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.biomaterials.2014.01.014","article-title":"A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus","volume":"35","author":"Varga","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.coviro.2016.09.003_bib0505","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chom.2012.08.009","article-title":"The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry","volume":"12","author":"Meertens","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2016.09.003_bib0510","doi-asserted-by":"crossref","first-page":"e1003232","DOI":"10.1371\/journal.ppat.1003232","article-title":"TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine","volume":"9","author":"Jemielity","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.09.003_bib0515","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.1508095112","article-title":"Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses","volume":"112","author":"Richard","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.09.003_bib0520","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1462-5822.2009.01345.x","article-title":"Alternative infectious entry pathways for dengue virus serotypes into mammalian cells","volume":"11","author":"Acosta","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0525","doi-asserted-by":"crossref","first-page":"e0140824","DOI":"10.1371\/journal.pone.0140824","article-title":"Dengue-3 virus entry into vero cells: role of clathrin-mediated endocytosis in the outcome of infection","volume":"10","author":"Piccini","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2016.09.003_bib0530","doi-asserted-by":"crossref","first-page":"e01956","DOI":"10.1128\/mBio.01956-15","article-title":"Vaccine and wild-type strains of yellow fever virus engage distinct entry mechanisms and differentially stimulate antiviral immune responses","volume":"7","author":"Fernandez-Garcia","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2016.09.003_bib0535","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/JVI.01399-12","article-title":"Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism","volume":"87","author":"Kalia","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0540","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/jiu377","article-title":"Repurposing of prochlorperazine for use against dengue virus infection","volume":"211","author":"Simanjuntak","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0545","doi-asserted-by":"crossref","first-page":"12019","DOI":"10.1128\/JVI.00300-07","article-title":"Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking","volume":"81","author":"van der Schaar","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0550","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.embor.embor866","article-title":"Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses","volume":"4","author":"Navarro-Sanchez","year":"2003","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coviro.2016.09.003_bib0555","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(90)90099-D","article-title":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein","volume":"174","author":"Randolph","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0560","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/vim.2014.0090","article-title":"Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys","volume":"28","author":"Farias","year":"2015","journal-title":"Viral Immunol"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0565","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0570","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1590\/S0074-02762013000500010","article-title":"Chloroquine use improves dengue-related symptoms","volume":"108","author":"Borges","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.coviro.2016.09.003_bib0575","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-virology-100114-055007","article-title":"Flaviviridae replication organelles: Oh, what a tangled web we weave","volume":"2","author":"Paul","year":"2015","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0580","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.03.005","article-title":"Requirement of cholesterol in the viral envelope for dengue virus infection","volume":"174","author":"Carro","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0585","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.09.003_bib0590","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1073\/pnas.1010811107","article-title":"Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis","volume":"107","author":"Heaton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.09.003_bib0595","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000321892","article-title":"Statins reduce dengue virus production via decreased virion assembly","volume":"54","author":"Martinez-Gutierrez","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0600","doi-asserted-by":"crossref","first-page":"e1002584","DOI":"10.1371\/journal.ppat.1002584","article-title":"Dengue virus infection perturbs lipid homeostasis in infected mosquito cells","volume":"8","author":"Perera","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.09.003_bib0605","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.virol.2013.04.003","article-title":"The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity","volume":"442","author":"Soto-Acosta","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0610","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","article-title":"Cholesterol biosynthesis modulation regulates dengue viral replication","volume":"389","author":"Rothwell","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0615","doi-asserted-by":"crossref","first-page":"e1000632","DOI":"10.1371\/journal.ppat.1000632","article-title":"Dengue virus capsid protein usurps lipid droplets for viral particle formation","volume":"5","author":"Samsa","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.09.003_bib0620","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2014.07.002","article-title":"Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus","volume":"109","author":"Soto-Acosta","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0625","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/hep.24619","article-title":"Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus","volume":"54","author":"Syed","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0630","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2011.11.014","article-title":"U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication","volume":"93","author":"Poh","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0635","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/civ949","article-title":"Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Whitehorn","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0640","doi-asserted-by":"crossref","first-page":"e87412","DOI":"10.1371\/journal.pone.0087412","article-title":"Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2","volume":"9","author":"Martinez-Gutierrez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2016.09.003_bib0645","doi-asserted-by":"crossref","first-page":"17176","DOI":"10.1073\/pnas.1009445107","article-title":"Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells","volume":"107","author":"Pollock","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.09.003_bib0650","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2014.00388","article-title":"ER stress, autophagy, and RNA viruses","volume":"5","author":"Jheng","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0655","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1743-422X-4-91","article-title":"Dengue virus serotype infection specifies the activation of the unfolded protein response","volume":"4","author":"Umareddy","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2016.09.003_bib0660","doi-asserted-by":"crossref","first-page":"14226","DOI":"10.1074\/jbc.M111.222703","article-title":"Dengue virus modulates the unfolded protein response in a time-dependent manner","volume":"286","author":"Pena","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.09.003_bib0665","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/AAC.04177-14","article-title":"The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication","volume":"59","author":"Carocci","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.09.003_bib0670","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","article-title":"A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection","volume":"210","author":"Fraser","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.03.006","article-title":"Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R-like endoplasmic reticulum kinase and elevates levels of eIF2alpha phosphorylation in virus infected cells","volume":"130","author":"Fraser","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0680","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1371\/journal.pntd.0000086","article-title":"Host gene expression profiling of dengue virus infection in cell lines and patients","volume":"1","author":"Fink","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0685","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1128\/JVI.02483-10","article-title":"Appraising the roles of CBLL1 and the ubiquitin\/proteasome system for flavivirus entry and replication","volume":"85","author":"Fernandez-Garcia","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0690","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2012.01.009","article-title":"A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication","volume":"165","author":"Nag","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0695","doi-asserted-by":"crossref","first-page":"e0004058","DOI":"10.1371\/journal.pntd.0004058","article-title":"Proteasome inhibition suppresses dengue virus egress in antibody dependent infection","volume":"9","author":"Choy","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0700","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0705","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0710","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(90)90029-7","article-title":"Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys","volume":"13","author":"Malinoski","year":"1990","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0715","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0720","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1128\/AAC.00561-10","article-title":"Characterization of dengue virus resistance to brequinar in cell culture","volume":"54","author":"Qing","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.09.003_bib0725","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","volume":"108","author":"Hoffmann","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.09.003_bib0730","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fgene.2014.00423","article-title":"Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection","volume":"5","author":"Ariumi","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.coviro.2016.09.003_bib0735","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1073\/pnas.1522987113","article-title":"Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents","volume":"113","author":"Brai","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.09.003_bib0740","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hep.22835","article-title":"The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naive hepatitis C patients","volume":"49","author":"Flisiak","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.09.003_bib0745","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2012.02.024","article-title":"The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection","volume":"57","author":"Hopkins","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0750","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.bmcl.2013.05.101","article-title":"Cyclophilin inhibitors as antiviral agents","volume":"23","author":"Peel","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coviro.2016.09.003_bib0755","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.09.003_bib0760","doi-asserted-by":"crossref","first-page":"e1000546","DOI":"10.1371\/journal.ppat.1000546","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.09.003_bib0765","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.03.007","article-title":"Targeting dengue virus NS4B protein for drug discovery","volume":"118","author":"Xie","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0770","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.00632-13","article-title":"The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase","volume":"87","author":"de","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0775","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1128\/JVI.00867-15","article-title":"A combined genetic-proteomic approach identifies residues within dengue virus NS4B critical for interaction with ns3 and viral replication","volume":"89","author":"Chatel-Chaix","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0780","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1128\/JVI.00855-15","article-title":"Discovery of dengue virus NS4B inhibitors","volume":"89","author":"Wang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0785","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.antiviral.2013.06.011","article-title":"Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions","volume":"99","author":"Chang","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0790","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/JVI.74.1.564-572.2000","article-title":"Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum","volume":"74","author":"Courageot","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.003_bib0795","doi-asserted-by":"crossref","first-page":"e0004524","DOI":"10.1371\/journal.pntd.0004524","article-title":"Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases\u2014not glycolipid processing enzymes","volume":"10","author":"Sayce","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.09.003_bib0800","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_bib0805","doi-asserted-by":"crossref","first-page":"e1005277","DOI":"10.1371\/journal.ppat.1005277","article-title":"dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins","volume":"11","author":"Scaturro","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.09.003_bib0810","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2012.07.008","article-title":"Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial","volume":"96","author":"Watanabe","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0815","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0820","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2015.12.008","article-title":"Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: the search for a window for potential therapeutic efficacy","volume":"127","author":"Watanabe","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.09.003_sbref0825","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/gutjnl-2013-306155","article-title":"Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C","volume":"64","author":"Xiao","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.coviro.2016.09.003_bib0830","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/AAC.04779-14","article-title":"Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors","volume":"59","author":"Yeo","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:45:21Z","timestamp":1749584721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716301250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":83,"alternative-id":["S1879625716301250"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.09.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The quest for host targets to combat dengue virus infections","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}